Establishment of an induced pluripotent stem cell line (FDEENTi001-A) from a patient with pathological myopia
Xinyue Bai, Xianjie Yang, Yun Cheng and 1 more
Stem Cell Research · 2019
doi:10.1016/j.scr.2018.101369 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Pathological myopia (PM) is a retinal degenerative disease with an increasing prevalence in Asia. The peripheral blood mononuclear cells (PBMCs) from a patient with PM were successfully reprogrammed to induced pluripotent stem cells (iPSCs) using integration-free method, Sendai viral (SeV) vectors expressing OCT4, SOX2, KLF4 and C-MYC. This line may provide a useful resource for exploring the pathogenesis of PM.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.